Q2 2025 Holdings
Filed 2025-08-14 | 146 holdings | $272.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| TAL Education Group(TAL) | SPONSORED ADS | 874080104 | $185.0K | 18,100 | 0.1% |
| Geron Corp(GERN) | COM | 374163103 | $187.1K | 132,711 | 0.1% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $233.7K | 35,958 | 0.1% |
| Tyra Biosciences Inc(TYRA) | COM | 90240B106 | $238.9K | 24,962 | 0.1% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $240.2K | 31,893 | 0.1% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $250.6K | 26,324 | 0.1% |
| Xencor Inc(XNCR) | COM | 98401F105 | $261.8K | 33,304 | 0.1% |
| CG Oncology Inc(CGON) | COM | 156944100 | $268.5K | 10,328 | 0.1% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $295.5K | 15,861 | 0.1% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $349.1K | 19,274 | 0.1% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $356.6K | 6,733 | 0.1% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $391.3K | 51,156 | 0.1% |
| Pharvaris N V(PHVS) | COM | N69605108 | $417.8K | 23,739 | 0.2% |
| Alibaba Group Hldg LTD(BABA) | SPONSORED ADS | 01609W102 | $426.1K | 3,757 | 0.2% |
| Alcon AG(ALC) | ORD SHS | H01301128 | $429.8K | 6,123 | 0.2% |
| Nokia Corp(NOK) | SPONSORED ADR | 654902204 | $432.5K | 83,500 | 0.2% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $467.8K | 47,633 | 0.2% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $473.2K | 11,680 | 0.2% |
| Perspective Therapeutics Inc(CATX) | COM NEW | 46489V302 | $475.9K | 138,350 | 0.2% |
| Trip COM Group LTD(CLV) | ADS | 89677Q107 | $495.9K | 8,456 | 0.2% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $513.3K | 2,974 | 0.2% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $518.0K | 149,701 | 0.2% |
| Corbus Pharmaceuticals Hldgs(CRBP) | COM NEW | 21833P301 | $519.5K | 75,292 | 0.2% |
| Evolus Inc(EOLS) | COM | 30052C107 | $534.6K | 58,042 | 0.2% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $534.6K | 40,684 | 0.2% |
| Kanzhun Limited(BZ) | SPONSORED ADS | 48553T106 | $560.2K | 31,400 | 0.2% |
| Jd.com Inc(JD) | SPON ADS CL A | 47215P106 | $626.1K | 19,183 | 0.2% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $636.9K | 52,247 | 0.2% |
| Natera Inc(NTRA) | COM | 632307104 | $678.1K | 4,014 | 0.2% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $690.5K | 61,268 | 0.3% |
| Madrigal Pharmaceuticals Inc(MDGL) | COM | 558868105 | $697.6K | 2,305 | 0.3% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $702.5K | 52,618 | 0.3% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $824.8K | 88,876 | 0.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $914.1K | 69,723 | 0.3% |
| Autoliv Inc(ALV) | COM | 052800109 | $951.2K | 8,500 | 0.3% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $953.5K | 40,473 | 0.4% |
| Icici Bank Limited(IBN) | ADR | 45104G104 | $977.1K | 29,047 | 0.4% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $989.0K | 20,953 | 0.4% |
| Hubspot Inc(HUBS) | COM | 443573100 | $1.0M | 1,800 | 0.4% |
| Hdfc Bank LTD(HDB) | SPONSORED ADS | 40415F101 | $1.0M | 13,241 | 0.4% |
| Soleno Therapeutics Inc(SLNO) | COM | 834203309 | $1.1M | 12,941 | 0.4% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $1.1M | 33,457 | 0.4% |
| LKQ Corp(LKQ) | COM | 501889208 | $1.1M | 29,500 | 0.4% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $1.1M | 31,230 | 0.4% |
| Shift4 Pmts Inc(FOUR) | CL A | 82452J109 | $1.1M | 11,300 | 0.4% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $1.1M | 10,909 | 0.4% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $1.2M | 40,864 | 0.4% |
| Kodiak Gas Svcs Inc(KGS) | COM | 50012A108 | $1.2M | 34,000 | 0.4% |
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $1.2M | 11,595 | 0.4% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $1.2M | 278,430 | 0.4% |